Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Genetic variability exceeds cell-type memory and determines iPSCs differentiation potential-implications for biobanking

ABSTRACT: Summary To address the issue of retention of somatic cell memory in iPSCs we compared gene expressions of genetically matched human iPSCs derived from fibroblasts and blood. We were using the all-in-one type footprint free SeVdp-iPS system, for generation of uniform iPSC lines Our results show that iPSC lines derived from the same donor are highly similar to each other. Overal design Total RNA was extracted from fibroblasts derived iPSC (N=8) and blood derived iPSC (N=10) as well as parental fibroblasts and peripheral blood mononuclear cells (N=4 different donors: T14; T42; T53; T55). Total RNA was also extracted from spontaneously differentiated Embryonic bodies derived from fibroblasts derived iPSC (N=4) and blood derived iPSC (N=4) from four donors. RNA from control human embryonic stem cell lines (H9, and FES22) was used as control. Samples were run in two different batches (1 and 2).

ORGANISM(S): Homo sapiens

SUBMITTER: Ras Trokovic 

PROVIDER: E-MTAB-3825 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Reports on the retention of somatic cell memory in induced pluripotent stem cells (iPSCs) have complicated the selection of the optimal cell type for the generation of iPSC biobanks. To address this issue we compared transcriptomic, epigenetic, and differentiation propensities of genetically matched human iPSCs derived from fibroblasts and blood, two tissues of the most practical relevance for biobanking. Our results show that iPSC lines derived from the same donor are highly similar to each oth  ...[more]

Similar Datasets

Genomics Genetic variability exceeds cell-type memory and determines iPSCs differentiation potential-implications for biobanking
2016-08-18 | E-MTAB-3859 | biostudies-arrayexpress
Transcriptomics Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [parental_lines_methylation]
2016-06-29 | E-GEOD-60923 | biostudies-arrayexpress
Transcriptomics Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [iPSCs_methylation 2]
2016-06-29 | E-GEOD-81452 | biostudies-arrayexpress
Unknown Differences in gene expression among AMD and non-AMD patients arise after initial fibroblasts are reprogrammed to iPSC and differentiation into RPE
2024-04-23 | GSE149202 | GEO
Transcriptomics Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [iPS_derived_erythroiblasts]
2016-06-29 | E-GEOD-60922 | biostudies-arrayexpress
Transcriptomics Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [Erythroid_lines]
2016-06-29 | E-GEOD-75095 | biostudies-arrayexpress
Transcriptomics aHDF- and PB-iPSC clones from the same individuals
2012-07-15 | E-GEOD-38153 | biostudies-arrayexpress
Transcriptomics Genome-wide gene expression patterns comparing various pluripotent stem cells.
2012-06-30 | E-GEOD-37077 | biostudies-arrayexpress
Transcriptomics Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [parental_lines_expression]
2016-06-29 | E-GEOD-73629 | biostudies-arrayexpress
Transcriptomics Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [iPSC_ESC_lines]
2016-06-29 | E-GEOD-75096 | biostudies-arrayexpress